Inovio Pharmaceuticals Inc (NASDAQ: INO) is -87.20% lower on its value in year-to-date trading and has touched a low of $1.30 and a high of $12.33 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The INO stock was last observed hovering at around $1.39 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $1.42, the stock is -14.37% and -24.54% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.71 million and changing 2.16% at the moment leaves the stock -47.70% off its SMA200. INO registered -22.40% loss for a year compared to 6-month gain of -25.65%. The firm has a 50-day simple moving average (SMA 50) of $1.8886 and a 200-day simple moving average (SMA200) of $2.73705.
The stock witnessed a -27.18% loss in the last 1 month and extending the period to 3 months gives it a -18.39%, and is 4.41% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.98% over the week and 7.60% over the month.
Inovio Pharmaceuticals Inc (INO) has around 134 employees, a market worth around $72.36M and $0.28M in sales. Profit margin for the company is -34079.58%. Distance from 52-week low is 9.23% and -88.48% from its 52-week high. The company has generated returns on investments over the last 12 months (-160.94%).
The EPS is expected to grow by 48.65% this year.
Inovio Pharmaceuticals Inc (INO) Top Institutional Holders
146.0 institutions hold shares in Inovio Pharmaceuticals Inc (INO), with institutional investors hold 37.56% of the company’s shares. The shares outstanding are 50.96M, and float is at 50.56M with Short Float at 10.88%. Institutions hold 37.28% of the Float.
The top institutional shareholder in the company is DEEP TRACK CAPITAL, LP with over 2.07 million shares valued at $16.7 million. The investor’s holdings represent 7.5988% of the INO Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 1.71 million shares valued at $13.79 million to account for 6.2741 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 1.58 million shares representing 5.8151% and valued at over $12.78 million, while GEODE CAPITAL MANAGEMENT, LLC holds 2.1428 of the shares totaling 0.58 million with a market value of $4.71 million.
Inovio Pharmaceuticals Inc (INO) Insider Activity
#####
